SUN-112 Arcuate 11-Betahydroxysteroid Dehydrogenase Type1 Regulates Energy Homeostasis

Introduction: Despite the ongoing increase in the prevalence of obesity, there are few licensed anti-obesity medications, and these therapies have limited efficacy and significant side effects. Therefore, new treatments are being developed, including 11-βhydroxysteroid dehydrogenase type1 (11βHSD1)...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Endocr Soc
Главные авторы: Izzi-Engbeaya, Chioma, Ma, Yue, Buckley, Niki, Ratnasabapathy, Risheka, Richardson, Errol, Counsell, John, Fernandes-Freitas, Isabel, Norton, Mariana, Farooq, Gala, Mirza, Zainab, Cheetham, Sharon, Seckl, Jonathan, Murphy, Kevin, Dhillo, Waljit, Gardiner, James
Формат: Artigo
Язык:Inglês
Опубликовано: Endocrine Society 2019
Предметы:
Adipose Tissue, Appetite, and Obesity
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6552872/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-112
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы